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Abstract
The malarial life cycle involves repeated rounds of intraerythrocytic replication interspersed by host cell rupture which
releases merozoites that rapidly invade fresh erythrocytes. Apical membrane antigen-1 (AMA1) is a merozoite protein that
plays a critical role in invasion. Antibodies against AMA1 prevent invasion and can protect against malaria in vivo, so AMA1
is of interest as a malaria vaccine candidate. AMA1 is efficiently shed from the invading parasite surface, predominantly
through juxtamembrane cleavage by a membrane-bound protease called SUB2, but also by limited intramembrane
cleavage. We have investigated the structural requirements for shedding of Plasmodium falciparum AMA1 (PfAMA1), and
the consequences of its inhibition. Mutagenesis of the intramembrane cleavage site by targeted homologous
recombination abolished intramembrane cleavage with no effect on parasite viability in vitro. Examination of PfSUB2-
mediated shedding of episomally-expressed PfAMA1 revealed that the position of cleavage is determined primarily by its
distance from the parasite membrane. Certain mutations at the PfSUB2 cleavage site block shedding, and parasites
expressing these non-cleavable forms of PfAMA1 on a background of expression of the wild type gene invade and replicate
normally in vitro. The non-cleavable PfAMA1 is also functional in invasion. However – in contrast to the intramembrane
cleavage site - mutations that block PfSUB2-mediated shedding could not be stably introduced into the genomic pfama1
locus, indicating that some shedding of PfAMA1 by PfSUB2 is essential. Remarkably, parasites expressing shedding-resistant
forms of PfAMA1 exhibit enhanced sensitivity to antibody-mediated inhibition of invasion. Drugs that inhibit PfSUB2 activity
should block parasite replication and may also enhance the efficacy of vaccines based on AMA1 and other merozoite
surface proteins.
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Introduction
The phylum Apicomplexa contains several pathogens of major
clinical and veterinary importance. These include the aetiological
agents of coccidiosis in poultry, theileriosis and babesiosis in cattle,
and toxoplasmosis, cryptosporidiosis and malaria in humans. In all
cases, the causative agents are parasitic protozoa that share the
feature of possessing several life-cycle stages that switch sequen-
tially between replicative intracellular forms and transiently
extracellular zoite stages equipped to seek out and invade suitable
host cells. Invasion by apicomplexan zoites has been a subject of
great attention for two major reasons: first, because it represents a
step at which the parasite is exposed to host antibodies and other
effector molecules capable of preventing invasion [1,2]; and
second, because it involves parasite-specific biochemical processes
– including a number of protease-dependent modifications [3] and
a specialised actinomyosin motor that drives motility and invasion
(reviewed in [4]) - that are potential targets for the development of
new antiparasite drugs.
The clinical manifestations of malaria stem from replication of
asexual blood stages of Plasmodium spp. in circulating erythrocytes.
In the case of the most dangerous malarial species, Plasmodium
falciparum, the parasite develops intracellularly over the course
of,48 hours to produce a mature schizont containing around 16
daughter merozoites. The schizont eventually ruptures, releasing
the merozoites which rapidly invade fresh erythrocytes, thus
perpetuating the cycle. Erythrocyte invasion comprises several
discrete steps [5–7], and is facilitated by the discharge of adhesive
ligands and other proteins onto the parasite surface from
specialised apical organelles called rhoptries and micronemes.
Invasion is also accompanied by efficient proteolytic shedding of
certain parasite surface and micronemal proteins. These include a
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an abundant glycosyl phosphatidylinositol-anchored merozoite
surface protein called MSP1 (which forms a complex with two
additional proteins called MSP6 and MSP7, collectively referred
to as the MSP1/6/7 complex). Shedding of these proteins goes
virtually to completion upon invasion [8–10]. Previous work from
our group and others has demonstrated that shedding of P.
falciparum AMA1 (PfAMA1) and the MSP1/6/7 complex, as well
as another micronemal protein called PTRAMP, is all mediated
by the same membrane-associated, calcium-dependent parasite
subtilisin-like serine protease called PfSUB2, which is itself
released from micronemes onto the merozoite surface during
invasion [11–13]. Precise mapping of the single PfSUB2 cleavage
sites in P. falciparum MSP1 and PfAMA1 has shown that the
sequences that flank the scissile bond lack obvious similarity
[12,14], leading us to suggest that PfSUB2 may share character-
istics with a number of vertebrate membrane-bound ’sheddases’
that cleave relatively unstructured juxtamembrane regions of their
protein substrates in a non sequence-dependent manner [15–20].
However, the requirements for substrate recognition by PfSUB2
have not been experimentally addressed.
In addition to PfSUB2-mediated shedding, under normal
conditions of in vitro culture a small fraction of PfAMA1 is also
shed by intramembrane cleavage [8,12], likely mediated by either
a parasite plasma membrane-localised rhomboid-like protease
called PfROM4 [21] or a micronemal rhomboid called PfROM1
[22]. Given the relatively low levels of this intramembrane
cleavage, we have previously postulated that it is physiologically
unimportant in P. falciparum. Intriguingly, however, shedding of the
Toxoplasma gondii AMA1 orthologue, TgAMA1, takes place
exclusively through intramembrane cleavage [8], mediated
predominantly through the action of the Toxoplasma orthologue
of ROM4 [23], and recent findings suggests that this shedding
plays a critical role in triggering parasite replication following
invasion [24]. There is no known functional homologue of
PfSUB2 in Toxoplasma, so the relative importance of PfSUB2-
mediated and intramembrane shedding of PfAMA1 remains
unclear.
Attempts to disrupt the single-copy P. falciparum PfSUB2 gene
(pfsub2) or its orthologue in the rodent malaria species P. berghei
have been unsuccessful, suggesting that SUB2 plays an indispens-
able role in parasite asexual blood-stages [11,25]. Consistent with
this, small molecules and monoclonal antibodies that bind
structures close to the PfSUB2 cleavage site in MSP1 efficiently
block shedding and also prevent invasion [26–29], suggesting that
shedding of the MSP1/6/7 complex is important for invasion. An
association between antibody-mediated inhibition of shedding and
invasion has also been noted for antibodies against PfAMA1 [29–
31], but other studies have suggested that certain antibodies to
PfAMA1 block invasion primarily by preventing its interactions
with a set of rhoptry neck-derived parasite partner proteins (RON
proteins) that are thought to associate with PfAMA1 at the moving
junction during invasion [32–36]. There is to date no firm
evidence that shedding of PfAMA1 is important for parasite
viability.
Like SUB2, both MSP1 and AMA1 are also indispensable in the
asexual blood stage life cycle, indicating that they play critical roles
[37–40]. Whilst MSP1 has orthologues only in other Plasmodium
species, AMA1 is conserved in most other apicomplexan genomes
examined [41–43]. In addition to its putative role in the transition
to replicative growth referred to above, AMA1 has also been
implicated in signalling events during invasion [44,45]. Both
AMA1 and MSP1 are widely considered potential malaria vaccine
candidates, since they can induce antibody responses that block
invasion in vitro and protect against blood-stage malaria in vivo (see
[46] and [47] for recent reviews). Many of the in vitro studies have
found that substantial concentrations of specific antibody (usually
.0.1 mg ml
21) are required to obtain a significant effect on
invasion (e.g. [9,48–50]. Perhaps in part as a result of this, clinical
trials of vaccines based on these two proteins have thus far proved
disappointing [51–54]. Shedding of apicomplexan zoite surface
proteins during invasion is frequently observed across the phylum
(reviewed in [55]), provoking speculation regarding its general
role. One proposal - that shedding may be required to disengage
adhesive interactions between parasite ligands and host cell
receptors - has received substantial experimental support
[21,23,56]. In addition, shedding may allow evasion of invasion-
inhibitory antibodies during invasion, as the shed molecules could
bind and deplete serum antibodies in the microenvironment of the
parasite-host cell interaction, as well as minimizing accumulation
of immune complexes on the parasite surface [57]. Though
intuitively attractive, there is no evidence supporting the latter
hypothesis.
Here we have investigated the structural requirements for
shedding of PfAMA1, and the consequences of its inhibition. We
first show that intramembrane cleavage of PfAMA1 can be
reduced to virtually undetectable levels by mutagenesis, with no
discernible phenotypic consequences. We then show that the
position of cleavage by PfSUB2 is determined primarily not by the
sequence at that site but by its distance from the transmembrane
domain (TMD). Despite this, certain radical mutations at the
PfSUB2 cleavage site can block shedding. Parasites expressing
these non-cleavable forms of PfAMA1 on a background of
expression of the wild type protein invade and replicate normally
in vitro. However, the same mutations that block PfSUB2-mediated
shedding could not be stably introduced into the parasite genome,
suggesting that some shedding of PfAMA1 by PfSUB2 is essential.
Furthermore, parasites expressing shedding-resistant mutants of
PfAMA1 are markedly more sensitive to antibody-mediated
inhibition of invasion than those expressing wild-type forms of
Author Summary
The malaria parasite invades red blood cells. During
invasion several parasite proteins, including a vaccine
candidate called PfAMA1, are clipped from the parasite
surface. Most of this clipping is performed by an enzyme
called PfSUB2, but some also occurs through intramem-
brane cleavage. The function of this shedding is unknown.
We have examined the requirements for shedding of
PfAMA1, and the effects of mutations that block shedding.
Mutations that block intramembrane cleavage have no
effect on the parasite. We then show that PfSUB2 does not
recognise a specific amino acid sequence in PfAMA1, but
rather cleaves it at a position determined primarily by its
distance from the parasite membrane. Certain mutations
at the PfSUB2 cleavage site prevent shedding, and
parasites expressing non-cleavable PfAMA1 along with
unmodified PfAMA1 grow normally. However, these
mutations cannot be introduced into the parasite’s
genome, showing that some shedding by PfSUB2 is
essential for parasite survival. Parasites expressing shed-
ding-resistant mutants of PfAMA1 show enhanced sensi-
tivity to invasion-inhibitory antibodies, suggesting that
shedding of surface proteins during invasion helps the
parasite to evade potentially protective antibodies. Drugs
that inhibit PfSUB2 may prevent disease and enhance the
efficacy of vaccines based on PfAMA1.
Functional Analysis of PfAMA1 Shedding
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invasion by apicomplexan zoites may also serve as a mechanism to
evade potentially protective invasion-inhibitory serum antibodies.
Results
Mutation of the intramembrane cleavage site in the
PfAMA1 TMD abolishes cleavage with no effect on
parasite viability
Precise mapping by us and others of the intramembrane
cleavage sites in PfAMA1 and TgAMA1 [8], as well as in the P.
falciparum microneme protein EBA-175 [21] and the other
Toxoplasma microneme proteins MIC2 [58] and MIC6 [59], has
shown in all cases that cleavage takes place on the C-terminal side
of an Ala residue (the P1 position in Schechter and Berger
terminology [60]). No detailed information is available about the
specific substrate requirements of PfROM4 or PfROM1, the
rhomboid-like enzymes potentially responsible for intramembrane
cleavage of PfAMA1. However, studies of several other rhomboids
from evolutionarily diverse organisms have indicated that only
residues with a small side-chain, such as Ala, Cys, Ser and Gly, can
be accommodated at P1, and that cleavage can often be prevented
by substitution of the P1 residue with bulky residues such as Tyr or
Phe [61,62]. To investigate the importance of intramembrane
shedding of PfAMA1, we therefore produced a construct designed
to modify the endogenous pfama1 gene by targeted homologous
recombination, replacing the P1 Ala550 with a Tyr residue
(Figure 1). Parasites transfected either with this construct (called
intAMA_R-TKmod) or with control construct intAMA_C-
TKmod (which is identical to intAMA_R-TKmod aside from
the Ala550Tyr substitution, and is thus designed to simply
reconstitute the authentic PfAMA1 TMD sequence) were
maintained in the presence of WR99210. After 2 cycles of drug
selection and ganciclovir treatment to enrich for integration
events, both parasite lines were cloned by limiting dilution.
Southern blot analysis of the obtained clones (Figure S1 in
Supporting Information Text S1) showed that integration of both
constructs had occurred in the expected manner, resulting in
transgenic parasites that should express PfAMA1 with either the
Ala550Tyr substitution or an unmodified TMD. Growth assays
showed no discernible growth defect in any of the clones, and
immunofluorescence analysis (IFA) and Western blot with
antibodies to PfAMA1 indicated no alteration in the sub-cellular
pattern or levels of PfAMA1 expression in schizonts (not shown).
To assess the effect of the mutation on shedding of PfAMA1,
mature schizonts enriched from synchronised cultures of clones
3D7_AMA_C_E9 (control) and 3D7_AMA_R_D4 (Ala550Tyr)
were allowed to undergo rupture in either normal medium, or
medium supplemented with the calcium chelator EGTA. This
compound has no effect on schizont rupture under the conditions
used, but efficiently inhibits both invasion and PfSUB2-mediated
shedding (which is calcium-dependent) whilst simultaneously
enhancing shedding by intramembrane cleavage, presumably
due to accumulation of PfAMA1 on the surface of released
merozoites [8,12]. As shown in Figure 2, the usual products of
PfSUB2 cleavage, PfAMA144 and PfAMA148, were equally
abundant in normal culture supernatants from both clones.
However, the 3D7_AMA_R_D4 supernatants were clearly
deficient in the PfAMA152 fragment which derives from
intramembrane cleavage. Furthermore, whereas in the case of
control clone 3D7_AMA_C_E9 the addition of EGTA resulted in
a relative increase in levels of shed PfAMA152, as expected, the
same treatment severely ablated all PfAMA1 shedding in the
mutant 3D7_AMA_R_D4 clone. Titration of the culture super-
natants by Western blot showed that the Ala550Tyr substitution
reduced production of the PfAMA152 fragment by a factor of at
least 8-fold (Figure S2 in Text S1). These results convincingly
demonstrate that the Ala550Tyr substitution in the PfAMA1
TMD efficiently blocks shedding of PfAMA1 by intramembrane
cleavage. The fact that the mutant clones show no growth
phenotype in vitro strongly suggests that intramembrane shedding
of PfAMA1 does not play a critical role in the asexual blood-stage
cycle of P. falciparum, or at least that only very low levels of
intramembrane cleavage (close to or below those detectable by
Western blot) are sufficient for normal parasite growth.
Non-sequence-dependent cleavage of PfAMA1 by
PfSUB2
Having shown to our satisfaction that normal levels of
intramembrane shedding of PfAMA1 are not essential in asexual
blood-stages, we turned our attention to the importance and
mechanism of juxtamembrane shedding. In previous work
[32,63,64] we have described episomal expression of a synthetic
recodonised FVO pfama1 transgene in P. falciparum. Expressed
under the control of the pfama1 promoter, the transgene product
(called PfAMA1/DIII-HA; Figure 1) is correctly trafficked to
micronemes and eventually to the merozoite surface, where it is
correctly cleaved and shed at erythrocyte invasion. The presence
of a single hemagglutinin (HA) epitope tag in the domain III loop
of the transgene product allows it to be discriminated from
endogenous PfAMA1, which continues to be expressed in the
transgenic lines. For the present study, we decided to use this same
episomal expression system to examine the sequence requirements
for cleavage by PfSUB2. To do this, we expressed a set of mutant
forms of PfAMA1/DIII-HA in P. falciparum and examined their
expression and proteolytic shedding. Most proteases recognise
specific amino acid residues immediately flanking the scissile bond,
so in initial experiments we examined the importance of these
residues in processing by PfSUB2. Constructs for episomal
expression of three mutants of PfAMA1/DIII-HA were first
generated, incorporating Ala substitutions of all three residues just
upstream of the cleavage site (positions P3–P1; mutant AMA_M1),
or the three residues downstream of the processing site (P19–P39;
mutant AMA_M2), or all six residues (P3–P39; mutant AMA_M3)
(Figure 1). As shown in Figure 3 panels A and B, examination by
IFA and Western blot using an HA-specific antibody showed that
all three mutant transgene products were expressed in transfected
parasites at levels equivalent to those of the parental construct
(AMA_C), and exhibited a similar pattern of sub-cellular
localisation and intracellular proteolytic prosequence removal as
is usually observed for PfAMA1 [65,66]. Most notably, examina-
tion of culture supernatants harvested following schizont rupture
and merozoite release revealed, in all cases, the presence of the
PfAMA148 species diagnostic of correct ectodomain shedding by
PfSUB2 (Figure 3C). Under carefully standardised culture
conditions there were no reproducible differences in the degree
of shedding or the apparent molecular mass of the shed PfAMA148
protein on SDS-PAGE. These results strongly suggest that
cleavage of PfAMA1 by PfSUB2 at the bond between residues
517–518 can occur efficiently irrespective of the precise amino
acid sequence immediately flanking the scissile bond.
The PfSUB2 cleavage site in PfAMA1 is primarily
determined by its distance from the transmembrane
domain
Anumberofreportsexaminingproteolyticcleavage ofmembrane-
bound proteins by membrane-associated sheddases have shown that
Functional Analysis of PfAMA1 Shedding
PLoS Pathogens | www.plospathogens.org 3 December 2011 | Volume 7 | Issue 12 | e1002448the site selected for cleavage, rather than being dependent on its
precise flanking sequence, is instead determined by its distance from
the membrane and its location within a relatively unstructured
juxtamembrane segment [15,16–20]. In the light of our above results,
we decided to exploit further mutants of PfAMA1/DIII-HA to
investigate whether a similar rule holds true for PfSUB2 cleavage of
PfAMA1. Mutant construct AMA_ins (Figure 1) was designed to
contain a perfect duplication of 21 residues (Glu526 – Lys546
inclusive) that lie within the residual ’stub’ that is normally left on the
merozoite surface after PfSUB2-mediated shedding of the bulk of the
PfAMA1 ectodomain. As a result, in AMA_ins the normal Thr517-
Ser518 PfSUB2 cleavage site within the motif AEVTQSNNE is
shifted substantially further away from the predicted TMD than its
position in the wild-type protein. We hypothesised that, should this
mutant remain sensitive to PfSUB2, cleavage would occur in one of
two manners dependent upon the mechanism of substrate recogni-
tion. If cleavage was strictly sequence-specific, cleavage would occur
as usual at the Thr517–Ser518 bond, resulting in the release of the
normal PfAMA148 product. If, on the other hand, the site of cleavage
was dependent on its distance from the membrane, cleavage would
now take place at a new site, probably at or around the position
indicated in Figure 1, since this would now lie 29 residues from the
TMD; importantly,the latter scenario wouldresultin the shedding of
a,2.5 kDa larger form of PfAMA148. As shown in Figure 4A and
4B, episomal expression of AMA_ins in transfected P. falciparum
resulted in the usual pattern of microneme localisation, and the
expression as expected of larger forms of intracellular anti-HA-
reactive PfAMA1, likely due to the presence of the 21 residue
(,2.6 kDa) insertion in AMA_ins. Examination of culture superna-
tants from this line (Figure 4C), showed that the shed form of
AMA_ins migrated on SDS-PAGE substantially more slowly than
the AMA_C-derived ’wild-type’ PfAMA148 species. These results are
consistent with the notion that PfSUB2-mediated shedding of
PfAMA1 is not primarily dependent on the flanking sequence but
takes place at a constant distance from the TMD, irrespective of the
amino acid sequence.
Figure 1. Mutants and antibodies used in this study. The overall architecture of PfAMA1/DIII-HA is shown schematically (left; not to scale),
including the three domains making up the PfAMA1 ectodomain (numbered), the position of the HA epitope tag within the membrane-proximal
domain III, the transmembrane domain (TMD; shown as a cylinder), and short cytoplasmic domain. The position of PfSUB2 cleavage, which lies 29
residues from the TMD between Thr517 and Ser518 [12], is indicated with a red dot. The nomenclature used for shed fragments of the ectodomain
resulting from juxtamembrane or intramembrane cleavage are indicated on the left. Note that PfAMA144 is derived from PfAMA148 as a result of an
internal ’nick’ within domain III; both are a result of shedding at the PfSUB2 site, whereas PfAMA152 arises from intramembrane shedding [12]. On the
right are shown the names of the parental construct (called AMA_C) for episomal expression of unmodified PfAMA1/DIII-HA, plus the various mutant
constructs, together with their corresponding sequence between the PfSUB2 cleavage site (arrowed, with flanking residues in bold) and the TMD
(shaded), which contains the intramembrane cleavage site (arrowed). Substitutions and insertions made are highlighted in yellow, whilst residues
removed in mutant AMA_del are indicated as dashes. The arrow against the AMA_ins sequence shows the predicted position of PfSUB2 cleavage in
this sequence if it is determined primarily by its distance from the TMD. The Ala550Tyr mutation was not expressed episomally, but introduced into
the genomic pfama1 gene as described in the text. The rat anti-PfAMA1 monoclonal antibody 4G2 used in this work recognizes an epitope formed by
domains I and II of PfAMA1 [32,63], whilst the rabbit and mouse polyclonal anti-PfAMA1 antibodies used were raised against a recombinant, correctly-
folded form of the entire ectodomain, expressed in Pichia pastoris [32,64].
doi:10.1371/journal.ppat.1002448.g001
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mediated cleavage in the AMA_ins transgene product, we decided
to isolate the shed product from culture supernatants for more
detailed structural examination. Attempts to affinity-purify it using
anti-HA antibodies failed, possibly due to poor solvent accessibility
of the domain III-located single HA epitope tag in the folded
protein. However, using a previously described method [66], we
successfully affinity-purified the shed protein using the anti-
PfAMA1 monoclonal antibody (mAb) 4G2. This mAb recognises
both the transgene product and endogenous PfAMA1, so the
purified preparations contained both forms of the protein;
however, staining and Western blot analysis with anti-HA
antibodies clearly discriminated the AMA_ins product, which
migrates slightly more slowly than the endogenous PfAMA152
species (Figure S3 in Text S1). Examination by LC/MS/MS of in-
gel tryptic digests of the AMA_ins fragment unambiguously
identified peptides spanning most of the predicted ectodomain
downstream of the known position of prosequence cleavage at
Ile97 [66] (Figure S4 in Text S1). Importantly, the most C-
terminal tryptic peptide identified, AEVTSNNEVVVK (predicted
monoisotopic m/z 1,288.67), has never been observed in digests of
wild-type PfAMA148 [12], confirming that cleavage of AMA_ins
takes place at a site downstream of the normal AEVTQSNNE site
(see Figure 1). We were unable to identify any peptide species
resembling DEYADIPEH, the expected C-terminal product of
tryptic digestion if cleavage of AMA_ins takes place as predicted in
Figure 1. Nonetheless, the presence of the AEVTSNNEVVVK
peptide, and absence of additional tryptic peptides C-terminal to
that sequence supports our prediction that cleavage of AMA_ins
occurs at or around the IPEHQKPTY motif. This in turn
supports the notion that PfSUB2-mediated shedding of PfAMA1 is
primarily dependent on its distance from the TMD and is not
constrained by primary sequence determinants flanking the
normal AEVTQSNNE site.
Expression of transgenes from episomal constructs in P.
falciparum is complicated by the fact that, even under continuous
selective drug pressure, episomes generally segregate poorly in the
parasite [67]. The result of this is that, at any one time, only a
fraction of the parasites in a drug-selected population express the
transgene of interest. Estimation of this fraction is possible using
antibodies specific for the transgene. IFA analysis of the various
lines described above using anti-HA and anti-PfAMA1 antibodies
showed reproducibly that ,30% of schizonts expressing PfAMA1
also exhibited expression of the transgenic PfAMA1/DIII-HA
(data not shown). On the other hand, accurate quantification of
relative abundance of the transgene product and endogenous gene
product in these parasites can be difficult, especially when (as in
the case of most of the mutants described above) the transgene
product migrates on SDS-PAGE similarly to the endogenous gene
product. Expression of the AMA_ins mutant, however, allowed us
to take advantage of its distinctly slower migration characteristics
to estimate its expression levels relative to that of endogenous
PfAMA1. As shown in Figure S5 in Text S1, titration by Western
Figure 2. Mutation of the intramembrane cleavage site in
PfAMA1 inhibits shedding by intramembrane processing.
Western blot analysis of culture supernatants from transgenic P.
falciparum clones 3D7_AMA_C_E9 (control) and 3D7_AMA_R_D4
(Ala550Tyr), following schizont rupture in the presence or absence of
10 mM EGTA. Samples were electrophoresed under reducing conditions
and probed with anti-PfAMA1 polyclonal serum R5 (top) or monoclonal
antibody 24C6.1F1 specific for the parasitophorous vacuole protein
SERA5, which is released in the form of the P50 fragment (bottom –
loading control). For both clones, shedding of PfAMA1 by PfSUB2 gives
rise to the expected products of PfAMA148 plus PfAMA144 ([12] and
Figure 1). In addition, PfAMA1 is shed from the surface of
3D7_AMA_C_E9 parasites via intra-membrane cleavage, giving rise to
PfAMA152.T h i ss p e c i e si sa b s e n tf r om 3D7_AMA_R_D4 culture
supernatants, confirming that the introduced Ala550Tyr substitution
blocks intramembrane processing of PfAMA1. Because PfSUB2-mediat-
ed shedding is calcium-dependent, virtually all PfAMA1 shedding is
ablated from the 3D7_AMA_R_D4 parasites in the presence of EGTA.
doi:10.1371/journal.ppat.1002448.g002
Figure 3. Alanine mutagenesis of the PfSUB2 cleavage site
does not affect expression, localisation or shedding of
PfAMA1. (A) IFA of drug-selected 3D7 parasites harbouring the
AMA_M3 construct. The transgenic PfAMA1/DIII-HA product detected
by anti-HA mAb 3F10 (green) co-localises with the microneme protein
EBA-175 (red) in mature segmented schizonts. The inset shows similar
staining of a free merozoite, where some translocation of PfAMA1/DIII-
HA onto the merozoite surface is detectable as is normal for
endogenous PfAMA1. Identical IFA patterns were observed in parasites
harbouring mutant constructs AMA_M1 and AMA_M2 (not shown). (B)
Western blot of parental 3D7 and transgenic parasite lines harbouring
construct AMA_C and mutants thereof. All show the characteristic
doublet corresponding to PfAMA183 (the full-length protein minus
signal peptide) and PfAMA166 (PfAMA183 minus its prosequence)
[12,66]. The transgene products are detected by anti-HA mAb 3F10 in
all lines except the parental 3D7 clone. (C) Western blot of culture
supernatants collected from the above lines. The shed PfAMA148
fragment derived from the transgenes is detected with anti-HA mAb
3F10, whilst a mAb (X509) reactive with a shed fragment of MSP1
(MSP133) serves as a loading control. Note that the single HA tag in
PfAMA1/DIII-HA spans the site of the internal ’nick’ in domain III that
normally produces PfAMA144, preventing the usual partial cleavage at
that site [32]; PfAMA144 is therefore never observed when probing
culture supernatants with the anti-HA antibodies.
doi:10.1371/journal.ppat.1002448.g003
Functional Analysis of PfAMA1 Shedding
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of the total PfAMA1 expressed by the AMA_ins line was in the
form of the larger AMA_ins products. This is also in approximate
concordance with the stained SDS PAGE analysis of the affinity-
purified protein shown in Figure S3 in Text S1. Taken together
with the IFA data this allowed us to estimate that, in those
individual parasites harbouring the episome, ,50% (15/30%) of
the total PfAMA1 expressed was derived from the transgene. Since
all PfAMA1/DIII-HA-expressing constructs used in this study
shared a common plasmid backbone and regulatory sequence, we
considered it reasonable to assume that this value holds for all
mutants examined. This was important for the interpretation of
subsequent experiments, as described below.
Radical mutagenesis of the PfSUB2 cleavage site blocks
shedding of PfAMA1
As described in the Introduction, it has been suggested that
efficient proteolytic shedding of PfAMA1 from the merozoite
surface is a prerequisite for successful erythrocyte invasion. In view
of our findings that straightforward Ala substitution of residues
immediately flanking the PfSUB2 cleavage site in PfAMA1 has no
effect on PfSUB2-mediated shedding, we decided to produce a
further series of mutant PfAMA1/DIII-HA expression constructs
designed to identify more radical substitutions around this site that
might prevent shedding. To assess the sensitivity of cleavage to
charged or large residues at the P1 and P19 positions, constructs
AMA_R1, AMA_Y1 and AMA_Y1-Y19 were first designed, in
which either the P1 position only was replaced with Arg or Tyr, or
both P1 and P19 positions were replaced with Tyr, respectively. In
addition, mutant AMA_F2 was produced, in which the P2 Val
residue was substituted with a Phe residue. Many proteases are
unable to cleave adjacent to Pro residues in a peptide chain, due to
the cyclic nature and conformational rigidity of the associated
imido bond; indeed, two adjacent Pro residues provide a high
degree of resistance to most proteases [68]. Accordingly, mutant
constructs AMA_P1 and AMA_P1-P19 were also produced,
respectively encoding Pro residues in positions P1 only, or in
both P1 and P19 relative to the PfSUB2 cleavage site (Figure 1).
The final mutant produced was AMA_del, in which 14 residues
(Glu531–Asn544 inclusive) that lie between the PfSUB2 cleavage
site and the TMD were deleted (Figure 1). This was predicted to
have the effect of bringing the globular domains I–III of PfAMA1/
DIII-HA closer to the membrane, rendering the cleavage site less
accessible to PfSUB2. It was also expected to result in a gene
product ,1.7 kDa smaller than the non-mutated PfAMA1/DIII-
HA expressed from construct AMA_C. Transfection of these
constructs into P. falciparum resulted in expression of all 7 transgene
products at levels approximately equivalent to those of the
parental construct AMA_C, with the same pattern of sub-cellular
localisation (not shown) and intracellular proteolytic prosequence
cleavage (Figure 5A–B). Examination of culture supernatants from
the parasite lines showed that shedding of the AMA_Y1,
AMA_Y1-Y19 and AMA_F2 transgene products was as efficient
as that of the control protein, supporting the conclusions of the
alanine mutagenesis studies that PfSUB2 shedding is not
dependent on the precise sequence at the cleavage site. Shedding
of the AMA_R1 mutant was also reproducibly efficient, although
in this case enhanced levels of the intramembrane cleavage
product PfAMA152 were also evident (Figure 5A). However,
shedding of the other mutant transgenes was substantially less
efficient, with decreased shedding of the AMA_del mutant and
virtually complete absence of shedding in the case of the AMA_P1
and AMA_P1–P19 mutants (Figure 5B). Further analysis of these
latter two lines by IFA showed a substantially increased proportion
of anti-HA reactive newly-invaded rings relative to the AMA_C
control, consistent with a severe defect in shedding of the PfAMA1
ectodomain at invasion (Figure 5C and 5D). The anti-HA signal in
these rings partially co-localised with that of a monoclonal
antibody against MSP119, the GPI-anchored MSP1-derived
fragment that remains on the merozoite surface following
PfSUB2-mediated cleavage of this protein at invasion (see Figure
S6 in Text S1). This shows that at least some of the transgenic
PfAMA1 carried into the rings was at the parasite plasma
membrane and not still resident in micronemes. Despite this, there
were no significant differences in growth rates between the control
transgenic line and any of the mutant lines over.20 growth cycles
(data not shown). Collectively, these results demonstrate that
certain major modifications of the PfSUB2 cleavage site within
PfAMA1 can effectively modify or block its shedding by the
protease, but that – under conditions of episomal PfAMA1
expression on a background of expression of the genomic wild-
type gene – this is not detectably deleterious to parasite growth in
vitro.
Some PfSUB2-mediated shedding of PfAMA1 is essential
in asexual blood-stages
In all the transgenic lines described above, expression of
PfAMA1/DIII-HA or mutants thereof takes place on a back-
ground of expression of the authentic wild-type pfama1 gene from
its genomic locus. Encouraged by our identification of mutations
capable of efficiently blocking shedding of the PfAMA1/DIII-HA
transgene products, we sought to determine whether these same
mutations could be introduced into the genomic pfama1 gene, as
Figure 4. The site of PfSUB2 cleavage in PfAMA1 depends
primarily upon its distance from the TMD. (A) IFA of drug-selected
3D7 parasites harbouring the AMA_ins construct. The transgene
product detected by anti-HA mAb 3F10 (green) co-localises correctly
with the microneme protein EBA-175 (red) in mature segmented
schizonts. (B) Western blot of parental 3D7 and transgenic parasite lines
harbouring constructs AMA_C and AMA_ins. The transgene-derived
PfAMA183 and PfAMA166 products are detected by anti-HA mAb 3F10.
Note that both species migrate more slowly in the case of AMA_ins,
consistent with the 21-residue insertion in this construct. An antibody
reactive with the parasite membrane protein Exp1 is used as a loading
control. (C) Western blot of culture supernatants collected from the
above lines. The shed transgenic PfAMA148 fragment (detected with
anti-HA mAb 3F10) is clearly of higher molecular mass in the case of
AMA_ins than in the case of the ’wild-type’ AMA_C construct. A mAb
(X509) reactive with a shed fragment of MSP1 (MSP133) serves as a
loading control.
doi:10.1371/journal.ppat.1002448.g004
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brane cleavage. This would be predicted to block all PfSUB2-
mediated shedding of endogenous PfAMA1, enabling us to
determine whether any shedding of the protein is required for
asexual blood-stage parasite viability. To do this, three new
constructs were produced, each designed to integrate into the
Figure 5. Radical mutagenesis of the cleavage site prevents PfSUB2-mediated shedding of PfAMA1. (A) and (B) Western blot of schizont
extracts and culture supernatants of parental 3D7 and transgenic parasite lines harbouring constructs AMA_C (included in both panels A and B as a
control), AMA_R1, AMA_Y1, AMA_Y1-Y1’, AMA_F2, AMA_P1, AMA_P1-P19, and AMA_del. The transgene-derived PfAMA183 and PfAMA166 products in
schizont extracts are detected by anti-HA mAb 3F10. An antibody reactive with the parasitophorous vacuole membrane protein Exp1 serves as a
loading control. Culture supernatants collected from the above lines were also probed with the anti-HA mAb 3F10. An antibody (mAb X509) reactive
with a shed fragment of MSP1 (MSP133) serves as a loading control. Note that the shed transgenic PfAMA148 fragment is virtually absent from
supernatants of the AMA_P1, AMA_P1-P19 and AMA_del mutants. (C) IFA of newly-invaded ring stages of the parasite line harbouring construct
AMA_P1. Note that, in contrast to the AMA_C line (not shown), many of the rings detectable with the DNA-reactive dye 4,6-diamidino-2-phenylindole
(DAPI; blue) demonstrated strong reactivity with the anti-HA mAb 3F10 (red). The Giemsa-stained field is from a different, stained thin film from the
same ring preparation. (D) Quantification of the proportion of anti-HA reactive rings in the AMA_P1, AMA_P1-P19 and AMA_C lines. The error bars
represent standard deviation (SD) values calculated from three different counts of the same experiment.
doi:10.1371/journal.ppat.1002448.g005
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Whereas integration of construct intAMA_C would effectively
reconstitute the sequence encoding the wild-type gene product
(thus acting as a control), integration of constructs intAMA_P1
and intAMA_P1-P19 was predicted to introduce Pro substitutions
of residues at either the P1 position or both the P1 and P19
positions respectively relative to the PfSUB2 cleavage site
(Figure 6A).
The three constructs were independently introduced into 3D7
parasites by transfection, and integrants selected for using a
standard drug cycling protocol. As shown in Figure 6B, in 2
independent experiments, PCR analysis of drug-resistant parasite
populations after 2 cycles of drug selection clearly detected the
predicted integration events in all cases, suggesting that parasites in
which integration had occurred were at least transiently viable.
However, examination of drug-selected lines by Southern blot
after 3 drug cycles (Figure 6C) showed integration only in the case
of construct intAMA_C, strongly suggesting that introduction of
either the P1 or P1-P19 Pro substitutions was deleterious to
parasite replication. Identical results were obtained using another
set of constructs, called intAMA_C_TK, intAMA_P1_TK and
intAMA_P1-P1’_TK, based on a pHHT-TK vector backbone
(not shown). Our findings suggest that complete blockade of
PfSUB2-mediated shedding of PfAMA1 impacts on parasite
viability and so cannot be tolerated by the parasite.
Shedding-resistant forms of PfAMA1 are functional in
invasion
Having failed to obtain viable parasites in which the
endogenous pfama1 gene was modified so as to block PfAMA1
shedding, we turned our attention back to the transgenic parasite
lines episomally expressing shedding-resistant mutants of
PfAMA1. PfAMA1 is a remarkably polymorphic molecule, with
documented naturally-occurring amino acid substitutions in at
least 52 positions within the ectodomain [69]. Previous work from
Foley and colleagues has identified a 20-residue peptide called R1
which binds to PfAMA1 in an allele-specific manner [70,71]. R1
potently inhibits erythrocyte invasion by those parasite strains that
express forms of PfAMA1 bound by the peptide, probably by
preventing interactions between PfAMA1 and its rhoptry neck-
derived RON partner proteins at invasion [72]. In two previous
studies of PfAMA1 function this strain-specific invasion-inhibitory
activity of R1 was elegantly exploited to evaluate functional
complementation by a series of episomally-expressed PfAMA1
mutants containing modifications within the cytoplasmic domain
[44,45]. We decided to take a similar approach to study the
functional competence of our episomally-expressed, shedding-
resistant PfAMA1 mutants. These are all based on the FVO
PfAMA1, which is not bound by R1, whereas the parental 3D7
parasite clone used throughout this work is fully sensitive to R1
[70]. Lines harbouring AMA_C, AMA_P1 and AMA_P1-P19
were synchronised in parallel with the parental 3D7 clone, then
allowed to undergo erythrocyte invasion in the presence or
absence of 100 mgm l
21 peptide R1. As shown in Figure 7,
invasion by the parental 3D7 was efficiently (,95%) blocked by
R1, as expected. In contrast, all three of the PfAMA1/DIII-HA-
expressing lines exhibited substantially higher levels of invasion,
indicating partial functional complementation by the transgene.
Importantly, the degree of complementation in each case (,20%)
was similar, indicating that the presence of the cleavage site
mutations has no appreciable impact on PfAMA1 function at
invasion. As a positive control in these assays we also included a
3D7-derived transgenic clone called 3D7-sgPfA1/HA.F5 [63] in
which the endogenous 3D7-type pfama1 gene has been entirely
replaced by targeted integration of a full-length copy of the same
synthetic FVO gene used in the PfAMA1/DIII-HA-expressing
lines; clone 3D7-sgPfA1/HA.F5 therefore expresses only the FVO
form of PfAMA1, but is otherwise isogenic with 3D7. As expected,
3D7-sgPfA1/HA.F5 was completely unaffected by the R1 peptide
(data not shown), unambiguously demonstrating that the effect of
R1 on invasion is solely a result of its capacity to bind PfAMA1.
Parasites expressing shedding-resistant forms of PfAMA1
exhibit enhanced susceptibility to invasion-inhibitory
anti-PfAMA1 antibodies
Inhibition of erythrocyte invasion by antibodies against AMA1
is widely documented, and has been an important contributory
factor to the continued interest in the molecule as a malaria
vaccine candidate. Although the mechanistic basis of antibody-
mediated invasion-inhibition remains controversial, it has been
suggested that shedding of AMA1 and other parasite surface
proteins may facilitate host cell entry by sequestering antibodies in
Figure 6. PfSUB2-mediated shedding of endogenous PfAMA1
is essential for asexual blood-stage parasite viability. (A)
Schematic representing integration construct intAMA_C (and mutant
forms intAMA_P1 and intAMA_P1-P19) designed to modify the pfama1
gene by single-crossover homologous recombination. The wild-type
pfama1 locus (wt, top) and the modified locus arising from the
expected integration even (int) are also shown. XbaI sites (X) used for
Southern blot analysis, and the relative positions of oligonucleotide
primers used for diagnostic PCR are also indicated (a, primer
verAMAint_F; b, primer verAMAint_R – see Table S1 in Text S1).
Authentic 3D7 pfama1 coding sequence is shown in pink, whilst
recodonised sequence encoding the FVO pfama1 coding sequence is in
light blue. The position of the PfSUB2 cleavage site is indicated (black
lollypop symbol). p, position of probe used for Southern blot analysis.
(B) PCR analysis of genomic DNA from wild-type parent 3D7 and
transgenic parasite lines harbouring constructs intAMA_C, intAMA_P1
and intAMA_P1-P1’ using primers verAMAint_F and verAMAint_R,
schematically represented in panel A. (C) Southern blot analysis of
XbaI-digested genomic DNA from wild-type 3D7 and transgenic lines
harbouring constructs intAMA_C, intAMA_P1 and intAMA_P1-P1’. The
expected sizes of fragments hybridizing with the probe were 12.2 kb
for the unmodified wild type locus and 7.0 kb in the case of the
expected integration event.
doi:10.1371/journal.ppat.1002448.g006
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preventing the accumulation of immune complexes on the parasite
surface that might interfere with invasion [55,57]. Having
produced parasite lines expressing shedding-resistant forms of
PfAMA1, we decided to take advantage of them to test this
hypothesis. Lines harbouring episomal constructs AMA_C,
AMA_P1 and AMA_P1-P19 were examined for their susceptibility
to two invasion-inhibitory anti-PfAMA1 antibody preparations:
the rat mAb 4G2 [32,63,73]; and rabbit polyclonal antibodies
raised against correctly folded recombinant PfAMA1 [64] (see
legend to Figure 1). The invasion-inhibition experiments were
performed using concentrations of antibodies that inhibit invasion
by the parental 3D7 clone by no more than ,20%, in order to
best enable us to distinguish differences in susceptibility to the
antibodies; preliminary experiments also demonstrated that the
parental clone and AMA_C line were equally sensitive to the
antibodies (Figure S7 in Text S1). In order to functionally
inactivate the endogenous, normally-shed PfAMA1 expressed by
the three parasite lines under investigation, thus focusing on the
effects of the antibodies on the episomally-expressed transgenic
PfAMA1, all assays comparing the three transgenic lines also
included R1 peptide at a concentration (100 mgm l
21) that
effectively blocks invasion by the parental 3F7 clone (see Figure 7).
As shown in Figure 8, under these conditions mutant lines
AMA_P1 and AMA_P1-P19 were reproducibly more sensitive
than the control AMA_C line to the invasion-inhibitory activity of
the antibodies. Since these mutants differ from AMA_C only by
the substitution of one (AMA_P1) or two (AMA_P1-P19) amino
acid residues that alter susceptibility to PfSUB2-mediated
shedding, these results strongly suggest that shedding of PfAMA1
indeed enables the parasite to evade invasion-inhibitory antibod-
ies.
Discussion
This study had three primary aims: to establish the importance
of intramembrane shedding of PfAMA1; to interrogate the
primary sequence requirements for cleavage of PfAMA1 by
PfSUB2; and to examine the functional consequences of
modifications that block that shedding. An intriguing aspect of
AMA1 is that, despite its conservation across the apicomplexan
phylum, it is not shed in a conserved manner. Shedding of
TgAMA1 is mediated exclusively by cleavage within the TMD by
a rhomboid-like protease [8], and recent elegant work from
Buguliskis and colleagues has implicated a Toxoplasma tachyzoite
surface rhomboid called TgROM4 in this [23]. Like TgROM4,
the P. falciparum orthologue of ROM4 is similarly expressed at the
merozoite surface [21], and this protease may be responsible for
the small fraction of PfAMA1 shedding that is mediated by
intramembrane cleavage [8]. In conflict with this is evidence from
another study using a cell-based in vitro assay of intramembrane
cleavage activity, which suggested that another parasite rhomboid
called PfROM1, but not PfROM4, has the capacity to shed
PfAMA1 [22]. Whichever enzyme is responsible, prior to this
study the biological relevance of this low-level rhomboid-mediated
cleavage of PfAMA1 was unknown, and indeed we have
previously speculated that it is artefactual [8]. Our ability here
to severely ablate intramembrane shedding (in the absence of
EGTA) by appropriate mutagenesis of the intra-TMD cleavage
site, with no effect on parasite growth, supports that. We cannot
formally rule out that very low level intramembrane shedding,
below the level of detection by Western blot, is important. This
possibility is highlighted by the observation that low-level
production of the PfAMA152 form could be detected under the
very artificial conditions of merozoite release in the presence of
EGTA, which enhances the products of intramembrane cleavage
presumably due to its blockade of both invasion and PfSUB2
activity [8,12]. This residual intramembrane shedding could be
due to incomplete blockade of cleavage by the Ala550Tyr
mutation, or even low-level phenotypic reversion of in culture of
the mutant, given the single-crossover nature of its genomic
modification. Collectively, however, we consider that the weight of
evidence argues against an essential role for intramembrane
cleavage of AMA1 in P. falciparum, a view in accord with the fact
that the Ala550 residue at which intramembrane cleavage of
Figure 7. Functional complementation by episomally-expressed PfAMA1 is unaffected by mutations that block PfSUB2-mediated
shedding. Histogram showing the effects of peptide R1 (100 mgm l
21 final concentration) on erythrocyte invasion by wild type 3D7 parasites or
transgenic lines harbouring constructs AMA_C, AMA_P1 or AMA_P1-P19. Normalised relative invasion efficiencies (expressed as % of controls) were
calculated by dividing the parasitaemia values of the R1-treated cultures with those of parallel cultures allowed to undergo invasion in the absence of
R1. Error bars indicate standard deviation values, calculated from 5 independent experiments.
doi:10.1371/journal.ppat.1002448.g007
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AMA1 TMD sequences; indeed several species lack an Ala residue
or any of the known ’helix-destabilising’ residues within the
luminal 8–10 residues of their TMD (Figure S8 in Text S1) that
are considered to be a signature of rhomboid substrates [61] (see
[74] for a recent review of this subject). It might therefore be
predicted that intramembrane cleavage of AMA1 is not a common
feature in Plasmodium.
In previous work we had noted that the sequences flanking the
PfSUB2 cleavage sites in MSP1 and PfAMA1 show no obvious
similarity, and so PfSUB2 was tentatively likened to the secretases
or ’sheddases’, a group of metalloproteases responsible for
shedding of ectodomains of membrane-associated proteins in
metazoa. A common characteristic of this group of proteases is
that they do not recognise specific sequence motifs but instead are
thought able to cleave within any relatively disordered sequence at
positions a certain distance from the membrane or a membrane
distal globular domain. Using episomal expression in the parasite
of epitope-tagged PfAMA1 transgenes, it was therefore not
completely surprising to us that substitution with Ala of all six
residues (P3-P3’) flanking the PfAMA1 cleavage site, or mutation
of the P1 Thr to Arg or Tyr, or the P2 Val to a Phe residue, or
even substitution of both P1 and P1’ residues with Tyr, had no
detectable effect on the efficiency of shedding. The shed cleavage
products from the AMA_M1, AMA_M2, AMA_M3, AMA_R1,
AMA_Y1, AMA_Y1-Y19 and AMA_F2 mutants co-migrated
precisely on SDS PAGE with those of the parental AMA_C
transgene product, leading us to conclude that cleavage of the
mutants likely takes place at the same position relative to the
TMD. The significance of the enhanced levels of the intramem-
brane cleavage product, PfAMA152, present in the AMA_R1
culture supernatants is presently unclear, but the site-specificity of
cleavage appeared unchanged. These conclusions were supported
by our subsequent observation that duplication of a 21-residue
sequence that lies between the canonical PfSUB2 cleavage site and
the TMD resulted in the shedding of an appropriately larger form
of the PfAMA1/DIII-HA ectodomain. Mass spectrometric
mapping of affinity-purified shed AMA_ins protein – although
failing to definitively assign the new site – confirmed cleavage
downstream of the normal position. This finding strongly suggests
that the position of cleavage is determined primarily by its distance
from the parasite membrane, fully supporting the sheddase
hypothesis. Our results are consistent with previous observations
regarding the lack of sequence conservation at the PfSUB2
processing site in AMA1 across Plasmodium species [8], and also the
observation that PTRAMP, a third PfSUB2 substrate [13],
contains no sequence motifs similar to either the PfAMA1 or
MSP1 cleavage sites. Presumably, the broad specificity of PfSUB2
enables it to cleave a range of membrane-bound substrates, largely
irrespective of their primary sequence. However, the fact that not
all merozoite surface proteins are shed by PfSUB2 [21] indicates
some degree of discrimination. Further work will be required to
establish the full repertoire of merozoite proteins that are
substrates for the protease, as well as the higher order structural
or other features that render a protein susceptible to PfSUB2. The
fact that the AMA_del mutant, in which part of the juxtamem-
brane ’stalk’ region was deleted, exhibited only poor cleavage may
indicate that a reasonably long such region is a minimal
requirement for targeting by PfSUB2.
The third part of our study addressed the effects of mutations at
the processing site that interfere with cleavage. As previously
observed for several other proteases, we found that the insertion of
Figure 8. Mutations that prevent PfSUB2-mediated shedding of PfAMA1 increase sensitivity to invasion-inhibitory anti-PfAMA1
antibodies. Histogram showing the effects of anti-PfAMA1 antibodies on invasion by transgenic P. falciparum lines harbouring PfAMA1/DIII-HA
expression constructs AMA_C, AMA_P1 or AMA_P1-P19. All assays were performed in the presence of peptide R1 (100 mgm l
21 final concentration) to
block the function of endogenous PfAMA1. Antibodies were used at 0.2 mg ml
21. Normalised relative invasion efficiencies (expressed as %) were
calculated by dividing the parasitaemia values of the antibody-treated cultures with those of parallel cultures allowed to undergo invasion in the
absence of antibodies (peptide R1 only). Error bars indicate standard deviation values.
doi:10.1371/journal.ppat.1002448.g008
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the scissile bond, very efficiently blocked shedding of the
PfAMA1/DIII-HA transgene product. We had anticipated that,
given the normally highly efficient shedding of PfAMA1 at
invasion, expression of such episomal constructs in the parasite
might be deleterious to parasite growth. In fact, we found that the
cleavage-resistant AMA_del, AMA_P1, or AMA_P1-P19 trans-
genes were expressed just as efficiently as the other transgene
mutants, and that the lines carrying them showed no detectable
growth defect. Focusing on the AMA_P1, or AMA_P1-P19
mutants, we used antibodies to the ectodomain-located HA
epitope tag to show that, consistent with the virtually complete
absence of shed ectodomain released into culture supernatants, the
mutant gene products were efficiently carried into host erythro-
cytes on the surface of invading merozoites. This proves
unambiguously that complete shedding is not a prerequisite for
invasion. Furthermore, using the R1 peptide, which blocks the
invasion-related function of 3D7 PfAMA1 in an allele-specific
manner, we showed that the FVO-based cleavage-resistant
mutants complemented the function of R1-inactivated endogenous
PfAMA1 as efficiently as the AMA_C-derived transgene product,
convincingly demonstrating that PfSUB2-mediated shedding is not
required for the function of PfAMA1 at invasion.
Given these findings, what is the explanation for our inability to
introduce the P1 and P1-P1’ mutations into the endogenous
pfama1 gene? One interpretation of this result is that although
PfSUB2-mediated cleavage of PfAMA1 is not essential for the
function of PfAMA1 during invasion, some shedding is essential at
some point in the asexual blood-stage life cycle. This notion is
supported by a recent study in Toxoplasma indicating that
intramembrane cleavage of TgAMA1 is required not for invasion,
but to trigger parasite replication following invasion [24]. Is it
possible that PfSUB2-mediated cleavage in P. falciparum performs
an analogous role to that of TgROM4 in Toxoplasma? Work is
underway to address this question.
Unlike many other microneme proteins (e.g. the erythrocyte
binding protein EBA-175 [21]) PfAMA1 is abundantly detected on
the surface of free merozoites, and indeed its discharge onto the
merozoite surface has been documented to occasionally occur
even prior to schizont rupture [65,75]. This, combined with the
established importance of AMA1 in invasion and its apparent
requirement to form interactions with the RON proteins, may
account for its relative sensitivity to antibodies compared with that
of other microneme proteins that have been examined, several of
which are predominantly discharged only upon contact with the
host cell (e.g. [76]). We took advantage of the episomal parasite
lines expressing shedding-resistant PfAMA1/DIII-HA to examine
their susceptibility to invasion-inhibition by anti-PfAMA1 anti-
bodies. Surprisingly, we found that the transgenic parasites
expressing the AMA_P1 or AMA_P1-P19 mutants were signifi-
cantly more sensitive to antibody-mediated invasion inhibition that
the control AMA_C line, indicating that shedding decreases
sensitivity to these antibodies. These assays focused on the
transgene products only, because they were all performed in the
presence of concentrations of the R1 peptide that effectively block
the function of the endogenous 3D7 PfAMA1. We can only
speculate on the mechanistic basis of this enhanced sensitivity.
Previous knockdown studies in Toxoplasma using a tetracycline-
regulated conditional system have indicated that TgAMA1 is
normally expressed at levels well in excess of those necessary to
sustain its role at invasion, since reduction of endogenous protein
levels by ,90% (upon replacement of the endogenous gene with a
regulated copy) had no effect on invasion efficiency [41]. We
hypothesise that if this is also the case in Plasmodium, and if only
those PfAMA1 molecules involved in interactions with the RON
complex play a productive role in invasion, it may be important
for the parasite to rapidly discard excess surface PfAMA1
molecules in the presence of anti-PfAMA1 antibodies in order to
prevent accumulation of antibody complexes on the parasite
surface that interfere with the parasite’s normally rapid passage
into the nascent parasitophorous vacuole. Thus, even though our
results clearly demonstrate that complete shedding from the
merozoite surface is not mechanistically essential for invasion to go
to completion, it may be evolutionarily advantageous for shedding
of PfAMA1 to occur in an efficient manner in order to cope with
the threat of host-derived anti-PfAMA1 antibodies.
In conclusion, our results suggest that shedding of PfAMA1 by
PfSUB2 may perform dual functions, one of which is essential and
the other of which enables the parasite to more efficiently evade
the host humoral response. Shedding of apicomplexan zoite
surface proteins is a widespread phenomenon [55], and our
observations have obvious implications for shedding of other
immunogenic parasite proteins too. Collectively, our findings
imply that efficient inhibition of PfSUB2 activity by suitable drug-
like inhibitors would prevent parasite growth, and – importantly –
that even partial inhibition of PfSUB2 activity may enhance the
efficacy of invasion-inhibitory anti-merozoite antibody responses in
vivo.
Materials and Methods
Plasmid construction
Constructs AMA_M1, AMA_M2, AMA_M3, AMA_R1,
AMA_Y1, AMA_Y1-Y19, AMA_F2, AMA_P1, AMA_P1-P1’,
and AMA_A550Y were produced by introducing mutations by
Quikchange site-directed mutagenesis (Stratagene) into plasmid
pST2A-sgPfa1 [32], then (in all cases except AMA_A550Y)
subcloning DNA fragments containing the mutations into plasmid
pHAM-sgA1/DIII-HA [32] (here renamed AMA_C for clarity),
using flanking AvrII and StuI restriction sites. To obtain construct
AMA_ins, AMA_C was digested with BsiWI and StuI and the
excised fragment replaced by a PCR product containing an
additional 65 bp encoding Glu526–Lys546 inclusive, in order to
duplicate this sequence in AMA_ins. The insert was PCR-
amplified from AMA_C using forward primer AMA1ins_F and
reverse primer AMA1ins_R (see Table S1 in Text S1 for all
primers used). Construct AMA_del was obtained by PCR-
amplification of sequence encoding residues Asn519-Asp530 using
primers AMA1del_F and AMA1ins_R, then subcloning the
resulting PCR product back into SpeI/StuI-digested AMA_C.
To produce integration constructs intAMA_R-TKmod and
intAMA_C-TKmod, one of the multiple cloning sites was first
removed from pHH-TK with restriction enzymes HpaI and KspI,
followed by blunting and religation, producing pHH-TKDMCS2.
The P. berghei dhfr 39 UTR (PbDT39) was then PCR-amplified from
pHH1 using primers PbDT39_ClaI_MCS_F and PbDT39_R and
subcloned into pHH-TKDMCS2, giving rise to plasmid pHH-
TKmod. Sequence including the mutation at the rhomboid
cleavage site in PfAMA1 was subcloned from AMA_A550Y into
intermediate plasmid PSL1180_AMA_C (see below) with restric-
tion enzymes SnaBI and StuI. The entire chimeric gene from this
plasmid, as well as the control chimera from PSL1180_AMA_C
was excised by restriction with XhoI and blunting the cut ends
followed by digestion with BglII. This was cloned into pHH-
TKmod pre-digested with BglII and HindII, producing intA-
MA_R-TKmod and intAMA_C-TKmod.
Integration constructs intAMA_C, intAMA_P1 and intA-
MA_P1-P19 were generated using AMA_C, AMA_P1 and
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pfama1 gene, excluding sequence encoding the first 4 Met residues,
was amplified from 3D7 genomic DNA using primers AMAint_F
and AMAint_R. This was cloned into plasmids AMA_C,
AMA_P1 and AMA_P1-P19 using restriction enzymes HpaI and
AvrII, replacing the pfama1 promoter sequence and 39 end of the
synthetic FVO ama1 gene and resulting in a partial in-frame
chimera between the targeting and synthetic coding sequences. To
obtain the derivatives intAMA_C_TK, intAMA_P1_TK and
intAMA_P1-P19_TK the entire chimeric coding sequence of each
construct plus its downstream P. berghei dhfr 39 UTR (PbDT39) was
excised with restriction enzymes HpaI and NotI, cloned into
plasmid PSL1180 (GE Healthcare) pre-digested with EcoRV and
NotI (to produce plasmids PSL1180_AMA_C, PSL1180_AMA_P1
and PSL1180_AMA_P1-P19) then the inserts excised with
restriction enzymes BglII and KspI and cloned into plasmid
pHHT-TK digested with the same enzymes. All final constructs
were confirmed by sequencing on both strands.
Parasite culture and transfection
P. falciparum clone 3D7 was maintained and synchronized as
described previously [77]. For transfection, ring-stage parasites (5–
10% parasitaemia) were electroporated with 100 mg of plasmid
DNA using standard procedures [11]. Episomal lines were
obtained by continuous selection with 10 nM WR99210 (Jacobus
Pharmaceuticals, New Jersey, USA), whereas to select for
integration in parasites transfected with plasmids intAMA_P1,
intAMA_C and intAMA_P1-P19, cultures were subjected to
repeated cycles of WR99210 treatment and removal as described
[11]. Parasites transfected with plasmids intAMA_R-TKmod,
intAMA_C-TKmod, intAMA_P1_TK, intAMA_C_TK and in-
tAMA_P1-P19_TK were expanded under selection with 2.5 nM
WR99210 and then treated with increasing concentrations of
gancyclovir (4 mM, 8 mM and 20 mM, for ,7 days at each
concentration) to select for parasites containing single copies of the
TK gene resulting from single-crossover integration of the input
plasmid into the pfama1 locus.
For invasion assays, schizonts were enriched by centrifugation
over cushions of 70% Percoll (GE Healthcare), added to fresh
erythrocytes to obtained a parasitaemia of ,4% and 1%
haematocrit, and cultured overnight in the presence or absence
of 100 mgm l
-1 R1 peptide, with or without the addition of 0.2 mg
ml
-1 mAb 4G2 or Protein G-purified IgG from the rabbit anti-
PfAMA1 antiserum Rb1, described previously [32]. Giemsa
stained thin blood films were prepared 16-18 h later and
parasitaemia values determined microscopically. Normalised
relative invasion efficiencies were calculated by dividing the
parasitaemia values of the R1-treated cultures with those of the
untreated samples, or by dividing the parasitaemia values of the
R1 plus antibody-treated samples with those of the R1 only-
treated cultures. For purified ring preparations, schizonts enriched
by centrifugation over cushions of 70% Percoll were cultured with
fresh erythrocytes for 3 hours to allow rupture and reinvasion,
then residual schizonts removed by repeated passage over 70%
Percoll cushions as described previously [9]. For analysis of
proteins released into Albumax-free culture supernatants, samples
were prepared as previously described [32].
Southern blot and diagnostic PCR
Genomic DNA from wild type and integration lines was
extracted using a QIAamp DNA blood mini kit (QIAGEN),
digested to completion with XbaI (for parasites transfected with
intAMA_P1, intAMA_C, intAMA_P1-P19,i n t A M A _ C _ T K ,
intAMA_P1_TK and intAMA_P1-P19_TK) or NdeI( f o rl i n e s
transfected with intAMA_R-TKmod and intAMA_C-TKmod),
electrophoresed on a 0.7% agarose gel, transferred to Hybond
N+ nylon membrane (GE Healthcare) using standard proce-
dures, and probed with [
32P]-labelled DNA fragments, pro-
duced using the Prime-It II random primer labelling kit
(Stratagene). The 39 region of the endogenous pfama1 gene
(amplified from genomic DNA with primers AMA1Sprobe_F
and AMA1Sprobe_R, Table S1 in Text S1) was used as a probe
in Southern blot hybridisations. Primers used for diagnostic
PCR reactions, called verAMAwt_R, verAMAint_F, and
verAMAint_R are also shown in Table S1 in Text S1. The
latter two are schematically represented in Figure 6A. PCR
reactions were performed using high fidelity Taq polymerase
(Invitrogen) according to the manufacturers’ instructions, with
30 amplification cycles using an annealing temperature of 55uC
and an extension time of 1 minute. As a negative control a
mixture of genomic DNA from 3D7 parasites and plasmid
intAMA_C was used as a template.
Antibodies, Western blot, and indirect
immunofluorescence assay (IFA)
Rabbit antibodies raised to correctly-folded recombinant FVO
PfAMA1, and the polyclonal mouse anti-PfAMA1 antibody R5
have been described previously [32,64], as has a polyclonal
antibody against EBA-175 [21], mAb 4G2 [63], the anti-SERA5
mAb 24C6.1F1 [78] and the anti-MSP1 mAb X509 [79]. A
polyclonal antibody against the parasitophorous vacuole protein
Exp1 was a kind gift of Klaus Lingelbach, University of Marburg,
Germany. For Western blot analysis, culture supernatants and
pellets of synchronous highly mature schizonts were solubilised in
SDS sample buffer and subjected to SDS-PAGE under reducing
conditions, followed by transfer to Hybond-C extra nitrocellulose
membrane (GE Healthcare). Membranes were probed with mAbs
or polyclonal antibodies as described previously [32]. For IFA, air
dried thin blood films were fixed in 4% (w/v) formaldehyde (Agar
Scientific Ltd.) for 30 min, permeabilized for 10 min with 0.1%
(w/v) Triton X100, then blocked for 1 h with 3% (w/v) bovine
serum albumin. After incubation for 30 min with the HA-specific
mAb 3F10 (Roche) diluted 1:200 and/or a rabbit polyclonal
antiserum raised against recombinant region VI of EBA175 [21]
diluted 1:500, films were washed for 5 min in PBS. Thin films
were then incubated with a biotinylated goat anti-rat IgG
(Chemicon) diluted 1:500, followed by incubation with FITC
streptavidin (Vector Laboratories) diluted 1:500 and with Alexa
Fluor 594 conjugated anti-rabbit antibody (Invitrogen) diluted
1:500. Nuclei were stained by 5 min immersion in 2 mgm l
21
DAPI in PBS, then washed in PBS. Samples were mounted in
Citifluor (Citifluor Ltd., Canterbury, U.K.), and images collected
using AxioVision 3.1 software on an Axioplan 2 Imaging system
(Zeiss) using a Plan-APOCHROMAT 1006/1.4 oil immersion
objective.
Affinity chromatography and mass spectrometry
PfAMA1 fragments shed into culture supernatants were
affinity-purified on a column of immobilised mAb 4G2 as
previously described [12,66]. Following SDS PAGE and staining
with InstantBlue (Generon), bands corresponding to proteins of
interest were excised and the proteins analysed by LC/MS/MS
as previously described [80]. LC/MS/MS data were searched
against the UniProt KB (release 15.5) protein database using the
Mascot search engine programme (Matrix Science, UK), as well
as against the predicted primary sequence of the AMA_ins
transgene.
Functional Analysis of PfAMA1 Shedding
PLoS Pathogens | www.plospathogens.org 12 December 2011 | Volume 7 | Issue 12 | e1002448Supporting Information
Text S1 Supplemental Figures S1 to S8, and Table S1.
(PDF)
Acknowledgments
The authors are grateful to Rachel Pitt for excellent technical input into the
early stages of this study.
Author Contributions
Conceived and designed the experiments: AO CRC CWM JMS MJB.
Performed the experiments: AO CRC FH CWM JM HRF. Analyzed the
data: AO CRC HRF JMS MJB. Contributed reagents/materials/analysis
tools: AO CRC FH JMS. Wrote the paper: AO CRC MJB.
References
1. Fraiture M, Baxter RH, Steinert S, Chelliah Y, Frolet C, et al. (2009) Two
mosquito LRR proteins function as complement control factors in the TEP1-
mediated killing of Plasmodium. Cell Host Microbe 5: 273–284.
2. Beeson JG, Osier FH, Engwerda CR (2008) Recent insights into humoral and
cellular immune responses against malaria. Trends Parasitol 24: 578–584.
3. O’Donnell RA, Blackman MJ (2005) The role of malaria merozoite proteases in
red blood cell invasion. Curr Opin Microbiol. 8: 422–427.
4. Soldati-Favre D (2008) Molecular dissection of host cell invasion by the
apicomplexans: the glideosome. Parasite 15: 197–205.
5. Dvorak JA, Miller LH, Whitehouse WC, Shiroishi T (1975) Invasion of
erythrocytes by malaria merozoites. Science 187: 748–750.
6. Aikawa M, Miller LH, Johnson J, Rabbege J (1978) Erythrocyte entry by
malarial parasites. A moving junction between erythrocyte and parasite. J Cell
Biol 77: 72–82.
7. Gilson PR, Crabb BS (2009) Morphology and kinetics of the three distinct
phases of red blood cell invasion by Plasmodium falciparum merozoites.
Int J Parasitol 39: 91–96.
8. Howell SA, Hackett F, Jongco AM, Withers-Martinez C, Kim K, et al. (2005)
Distinct mechanisms govern proteolytic shedding of a key invasion protein in
apicomplexan pathogens. Mol Microbiol 57: 1342–1356.
9. Blackman MJ, Heidrich HG, Donachie S, McBride JS, Holder AA (1990) A
single fragment of a malaria merozoite surface protein remains on the parasite
during red cell invasion and is the target of invasion-inhibiting antibodies. J Exp
Med 172: 379–382.
10. Blackman MJ, Chappel JA, Shai S, Holder AA (1993) A conserved parasite
serine protease processes the Plasmodium falciparum merozoite surface protein-
1. Mol Biochem Parasitol 62: 103–114.
11. Harris PK, Yeoh S, Dluzewski AR, O’Donnell RA, Withers-Martinez C, et al.
(2005) Molecular identification of a malaria merozoite surface sheddase. PLoS
Pathog 1: 241–251.
12. Howell SA, Well I, Fleck SL, Kettleborough C, Collins CR, et al. (2003) A single
malaria merozoite serine protease mediates shedding of multiple surface proteins
by juxtamembrane cleavage. J Biol Chem 278: 23890–23898.
13. Green JL, Hinds L, Grainger M, Knuepfer E, Holder AA (2006) Plasmodium
thrombospondin related apical merozoite protein (PTRAMP) is shed from the
surface of merozoites by PfSUB2 upon invasion of erythrocytes. Mol Biochem
Parasitol 150: 114–117.
14. Blackman MJ, Ling IT, Nicholls SC, Holder AA (1991) Proteolytic processing of
the Plasmodium falciparum merozoite surface protein-1 produces a membrane-
bound fragment containing two epidermal growth factor-like domains. Mol
Biochem Parasitol 49: 29–33.
15. Schlondorff J, Blobel CP (1999) Metalloprotease-disintegrins: modular proteins
capable of promoting cell-cell interactions and triggering signals by protein-
ectodomain shedding. J Cell Sci 112 ( Pt 21): 3603–3617.
16. Wang X, He K, Gerhart M, Huang Y, Jiang J, et al. (2002) Metalloprotease-
mediated GH receptor proteolysis and GHBP shedding. Determination of
extracellular domain stem region cleavage site. J Biol Chem 277: 50510–50519.
17. Schwager SL, Chubb AJ, Woodman ZL, Yan L, Mentele R, et al. (2001)
Cleavage of disulfide-bridged stalk domains during shedding of angiotensin-
converting enzyme occurs at multiple juxtamembrane sites. Biochemistry 40:
15624–15630.
18. Pang S, Chubb AJ, Schwager SL, Ehlers MR, Sturrock ED, et al. (2001) Roles of
the juxtamembrane and extracellular domains of angiotensin-converting enzyme
in ectodomain shedding. Biochem J 358: 185–192.
19. Tanaka K, Chazenbalk GD, McLachlan SM, Rapoport B (2000) Evidence that
cleavage of the thyrotropin receptor involves a "molecular ruler" mechanism:
deletion of amino acid residues 305-320 causes a spatial shift in cleavage site 1
independent of amino acid motif. Endocrinology 141: 3573–3577.
20. Maruyama K, Kametani F, Usami M, Yamao-Harigaya W, Tanaka K (1991)
"Secretase," Alzheimer amyloid protein precursor secreting enzyme is not
sequence-specific. Biochem Biophys Res Commun 179: 1670–1676.
21. O’Donnell RA, Hackett F, Howell SA, Treeck M, Struck N, et al. (2006)
Intramembrane proteolysis mediates shedding of a key adhesin during
erythrocyte invasion by the malaria parasite. J Cell Biol 174: 1023–1033.
22. Baker RP, Wijetilaka R, Urban S (2006) Two Plasmodium rhomboid proteases
preferentially cleave different adhesins implicated in all invasive stages of
malaria. PLoS Pathog 2: e113.
23. Buguliskis JS, Brossier F, Shuman J, Sibley LD (2010) Rhomboid 4 (ROM4)
affects the processing of surface adhesins and facilitates host cell invasion by
Toxoplasma gondii. PLoS Pathog 6: e1000858.
24. Santos JM, Ferguson DJ, Blackman MJ, Soldati-Favre D (2011) Intramembrane
Cleavage of AMA1 Triggers Toxoplasma to Switch from an Invasive to a
Replicative Mode. Science 331: 473–477.
25. Uzureau P, Barale JC, Janse CJ, Waters AP, Breton CB (2004) Gene targeting
demonstrates that the Plasmodium berghei subtilisin PbSUB2 is essential for red
cell invasion and reveals spontaneous genetic recombination events. Cell
Microbiol 6: 65–78.
26. Fleck SL, Birdsall B, Babon J, Dluzewski AR, Martin SR, et al. (2003) Suramin
and suramin analogues inhibit merozoite surface protein-1 secondary processing
and erythrocyte invasion by the malaria parasite Plasmodium falciparum. J Biol
Chem 278: 47670–47677.
27. Blackman MJ, Scott-Finnigan TJ, Shai S, Holder AA (1994) Antibodies inhibit
the protease-mediated processing of a malaria merozoite surface protein. J Exp
Med 180: 389–393.
28. Uthaipibull C, Aufiero B, Syed SE, Hansen B, Guevara Patino JA, et al. (2001)
Inhibitory and blocking monoclonal antibody epitopes on merozoite surface
protein 1 of the malaria parasite Plasmodium falciparum. J Mol Biol 307:
1381–1394.
29. Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H (2010) Antibodies
against multiple merozoite surface antigens of the human malaria parasite
Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
Malar J 9: 77.
30. Dutta S, Haynes JD, Moch JK, Barbosa A, Lanar DE (2003) Invasion-inhibitory
antibodies inhibit proteolytic processing of apical membrane antigen 1 of
Plasmodium falciparum merozoites. Proc Natl Acad Sci U S A 100:
12295–12300.
31. Dutta S, Haynes JD, Barbosa A, Ware LA, Snavely JD, et al. (2005) Mode of
action of invasion-inhibitory antibodies directed against apical membrane
antigen 1 of Plasmodium falciparum. Infect Immun 73: 2116–2122.
32. Collins CR, Withers-Martinez C, Hackett F, Blackman MJ (2009) An inhibitory
antibody blocks interactions between components of the malarial invasion
machinery. PLoS Pathog 5: e1000273.
33. Alexander DL, Arastu-Kapur S, Dubremetz JF, Boothroyd JC (2006)
Plasmodium falciparum AMA1 binds a rhoptry neck protein homologous to
TgRON4, a component of the moving junction in Toxoplasma gondii. Eukaryot
Cell 5: 1169–1173.
34. Lamarque M, Besteiro S, Papoin J, Roques M, Vulliez-Le Normand B, et al.
(2011) The RON2-AMA1 interaction is a critical step in moving junction-
dependent invasion by apicomplexan parasites. PLoS Pathog 7: e1001276.
35. Tonkin ML, Roques M, Lamarque MH, Pugniere M, Douguet D, et al. (2011)
Host cell invasion by apicomplexan parasites: insights from the co-structure of
AMA1 with a RON2 peptide. Science 333: 463–467.
36. Tyler JS, Boothroyd JC (2011) The C-terminus of Toxoplasma RON2 provides
the crucial link between AMA1 and the host-associated invasion complex. PLoS
Pathog 7: e1001282.
37. Triglia T, Healer J, Caruana SR, Hodder AN, Anders RF, et al. (2000) Apical
membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium
species. Mol Microbiol 38: 706–718.
38. O’Donnell RA, Saul A, Cowman AF, Crabb BS (2000) Functional conservation
of the malaria vaccine antigen MSP-119across distantly related Plasmodium
species. Nat Med 6: 91–95.
39. Drew DR, O’Donnell RA, Smith BJ, Crabb BS (2004) A common cross-species
function for the double epidermal growth factor-like modules of the highly
divergent plasmodium surface proteins MSP-1 and MSP-8. J Biol Chem 279:
20147–20153.
40. Combe A, Giovannini D, Carvalho TG, Spath S, Boisson B, et al. (2009) Clonal
conditional mutagenesis in malaria parasites. Cell Host Microbe 5: 386–396.
41. Mital J, Meissner M, Soldati D, Ward GE (2005) Conditional Expression of
Toxoplasma gondii Apical Membrane Antigen-1 (TgAMA1) Demonstrates That
TgAMA1 Plays a Critical Role in Host Cell Invasion. Mol Biol Cell 16:
4341–4349.
42. Hehl AB, Lekutis C, Grigg ME, Bradley PJ, Dubremetz JF, et al. (2000)
Toxoplasma gondii homologue of plasmodium apical membrane antigen 1 is
involved in invasion of host cells. Infect Immun 68: 7078–7086.
43. Gaffar FR, Yatsuda AP, Franssen FF, de Vries E (2004) Erythrocyte invasion by
Babesia bovis merozoites is inhibited by polyclonal antisera directed against
peptides derived from a homologue of Plasmodium falciparum apical membrane
antigen 1. Infect Immun 72: 2947–2955.
Functional Analysis of PfAMA1 Shedding
PLoS Pathogens | www.plospathogens.org 13 December 2011 | Volume 7 | Issue 12 | e100244844. Leykauf K, Treeck M, Gilson PR, Nebl T, Braulke T, et al. (2010) Protein kinase
a dependent phosphorylation of apical membrane antigen 1 plays an important
role in erythrocyte invasion by the malaria parasite. PLoS Pathog 6: e1000941.
45. Treeck M, Zacherl S, Herrmann S, Cabrera A, Kono M, et al. (2009) Functional
analysis of the leading malaria vaccine candidate AMA-1 reveals an essential
role for the cytoplasmic domain in the invasion process. PLoS Pathog 5:
e1000322.
46. Remarque EJ, Faber BW, Kocken CH, Thomas AW (2008) Apical membrane
antigen 1: a malaria vaccine candidate in review. Trends Parasitol 24: 74–84.
47. Holder AA (2009) The carboxy-terminus of merozoite surface protein 1:
structure, specific antibodies and immunity to malaria. Parasitology 136:
1445–1456.
48. Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, et al. (2009) Anti-apical-
membrane-antigen-1 antibody is more effective than anti-42-kilodalton-mero-
zoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as
determined by the in vitro growth inhibition assay. Clin Vaccine Immunol 16:
963–968.
49. Malkin EM, Diemert DJ, McArthur JH, Perreault JR, Miles AP, et al. (2005)
Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage
vaccine for Plasmodium falciparum malaria. Infect Immun 73: 3677–3685.
50. Roestenberg M, Remarque E, de Jonge E, Hermsen R, Blythman H, et al.
(2008) Safety and immunogenicity of a recombinant Plasmodium falciparum
AMA1 malaria vaccine adjuvanted with Alhydrogel, Montanide ISA 720 or
AS02. PLoS One 3: e3960.
51. Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, et al. (2009) A randomized
controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria
vaccine in children in Mali. Vaccine 27: 3090–3098.
52. Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, et al. (2009)
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1
(AMA-1) administered in adjuvant system AS01B or AS02A. PLoS One 4:
e5254.
53. Thompson FM, Porter DW, Okitsu SL, Westerfeld N, Vogel D, et al. (2008)
Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa
clinical trial. PLoS One 3: e1493.
54. Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, et al. (2009) Blood
stage malaria vaccine eliciting high antigen-specific antibody concentrations
confers no protection to young children in Western Kenya. PLoS One 4: e4708.
55. Carruthers VB, Blackman MJ (2005) A new release on life: emerging concepts in
proteolysis and parasite invasion. Mol Microbiol 55: 1617–1630.
56. Brossier F, Jewett TJ, Lovett JL, Sibley LD (2003) C-terminal processing of the
toxoplasma protein MIC2 is essential for invasion into host cells. J Biol Chem
278: 6229–6234.
57. Saul A (1987) Kinetic constraints on the development of a malaria vaccine.
Parasite Immunol 9: 1–9.
58. Zhou XW, Blackman MJ, Howell SA, Carruthers VB (2004) Proteomic analysis
of cleavage events reveals a dynamic two-step mechanism for proteolysis of a key
parasite adhesive complex. Mol Cell Proteomics. 3: 565–576.
59. Opitz C, Di Cristina M, Reiss M, Ruppert T, Crisanti A, et al. (2002)
Intramembrane cleavage of microneme proteins at the surface of the
apicomplexan parasite Toxoplasma gondii. EMBO J 21: 1577–1585.
60. Schechter I, Berger A (1967) On the size of the active site in proteases. I. Papain.
Biochem Biophys Res Commun 27: 157–162.
61. Strisovsky K, Sharpe HJ, Freeman M (2009) Sequence-specific intramembrane
proteolysis: identification of a recognition motif in rhomboid substrates. Mol Cell
36: 1048–1059.
62. Akiyama Y, Maegawa S (2007) Sequence features of substrates required for
cleavage by GlpG, an Escherichia coli rhomboid protease. Mol Microbiol 64:
1028–1037.
63. Collins CR, Withers-Martinez C, Bentley GA, Batchelor AH, Thomas AW,
et al. (2007) Fine Mapping of an Epitope Recognized by an Invasion-inhibitory
Monoclonal Antibody on the Malaria Vaccine Candidate Apical Membrane
Antigen 1. J Biol Chem 282: 7431–7441.
64. Pizarro JC, Normand BV, Chesne-Seck ML, Collins CR, Withers-Martinez C,
et al. (2005) Crystal structure of the malaria vaccine candidate apical membrane
antigen 1. Science 308: 408–411.
65. Narum DL, Thomas AW (1994) Differential localization of full-length and
processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium
falciparum merozoites. Mol Biochem Parasitol 67: 59–68.
66. Howell SA, Withers-Martinez C, Kocken CH, Thomas AW, Blackman MJ
(2001) Proteolytic processing and primary structure of Plasmodium falciparum
apical membrane antigen-1. J Biol Chem 276: 31311–31320.
67. O’Donnell RA, Freitas-Junior LH, Preiser PR, Williamson DH, Duraisingh M,
et al. (2002) A genetic screen for improved plasmid segregation reveals a role for
Rep20 in the interaction of Plasmodium falciparum chromosomes. EMBO J 21:
1231–1239.
68. Vanhoof G, Goossens F, De Meester I, Hendriks D, Scharpe S (1995) Proline
motifs in peptides and their biological processing. Faseb J 9: 736–744.
69. Chesne-Seck ML, Pizarro JC, Normand BV, Collins CR, Blackman MJ, et al.
(2005) Structural comparison of apical membrane antigen 1 orthologues and
paralogues in apicomplexan parasites. Mol Biochem Parasitol 144: 55–67.
70. Harris KS, Casey JL, Coley AM, Masciantonio R, Sabo JK, et al. (2005) Binding
hot spot for invasion inhibitory molecules on Plasmodium falciparum apical
membrane antigen 1. Infect Immun 73: 6981–6989.
71. Harris KS, Casey JL, Coley AM, Karas JA, Sabo JK, et al. (2009) Rapid
optimization of a peptide inhibitor of malaria parasite invasion by comprehen-
sive N-methyl scanning. J Biol Chem 284: 9361–9371.
72. Richard D, MacRaild CA, Riglar DT, Chan JA, Foley M, et al. (2010)
Interaction between Plasmodium falciparum apical membrane antigen 1 and the
rhoptry neck protein complex defines a key step in the erythrocyte invasion
process of malaria parasites. J Biol Chem 285: 14815–14822.
73. Kocken CH, van der Wel AM, Dubbeld MA, Narum DL, van de Rijke FM,
et al. (1998) Precise timing of expression of a Plasmodium falciparum-derived
transgene in Plasmodium berghei is a critical determinant of subsequent
subcellular localization. J Biol Chem 273: 15119–15124.
74. Urban S (2010) Taking the plunge: integrating structural, enzymatic and
computational insights into a unified model for membrane-immersed rhomboid
proteolysis. Biochem J 425: 501–512.
75. Waters AP, Thomas AW, Deans JA, Mitchell GH, Hudson DE, et al. (1990) A
merozoite receptor protein from Plasmodium knowlesi is highly conserved and
distributed throughout Plasmodium. J Biol Chem 265: 17974–17979.
76. Gantt S, Persson C, Rose K, Birkett AJ, Abagyan R, et al. (2000) Antibodies
against thrombospondin-related anonymous protein do not inhibit Plasmodium
sporozoite infectivity in vivo. Infect Immun 68: 3667–3673.
77. Blackman MJ (1994) Purification of Plasmodium falciparum merozoites for
analysis of the processing of merozoite surface protein-1. Methods Cell Biol 45:
213–220.
78. Delplace P, Dubremetz JF, Fortier B, Vernes A (1985) A 50 kilodalton
exoantigen specific to the merozoite release-reinvasion stage of Plasmodium
falciparum. Mol Biochem Parasitol 17: 239–251.
79. Blackman MJ, Whittle H, Holder AA (1991) Processing of the Plasmodium
falciparum major merozoite surface protein-1: identification of a 33-kilodalton
secondary processing product which is shed prior to erythrocyte invasion. Mol
Biochem Parasitol 49: 35–44.
80. Silmon de Monerri NC, Flynn HR, Campos MG, Hackett F, Koussis K, et al.
(2011) Global Identification of Multiple Substrates for PfSUB1, an Essential
Malarial Processing Protease. Infect Immun 79: 1086–1097.
Functional Analysis of PfAMA1 Shedding
PLoS Pathogens | www.plospathogens.org 14 December 2011 | Volume 7 | Issue 12 | e1002448